| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...870786S |
| P356 | DOI | 10.1371/JOURNAL.PONE.0070786 |
| P932 | PMC publication ID | 3743876 |
| P698 | PubMed publication ID | 23967107 |
| P5875 | ResearchGate publication ID | 256073039 |
| P50 | author | Heitor S de Souza | Q38326511 |
| Ronir Raggio Luiz | Q40056984 | ||
| P2093 | author name string | Deborah Biasoli | |
| Helena Lobo Borges | |||
| Rossana Colla Soletti | |||
| Nathassya Accioly Lins Vidal Rodrigues | |||
| P2860 | cites work | Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease | Q22242053 |
| Historical Aspects of Inflammatory Bowel Disease | Q22242797 | ||
| The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells | Q24314491 | ||
| Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation. | Q53353383 | ||
| Identification of candidate genes in ulcerative colitis and Crohn's disease using cDNA array technology. | Q53395700 | ||
| Expression of beta-catenin and full-length APC protein in normal and neoplastic colonic tissues. | Q53404425 | ||
| Cortisone in ulcerative colitis; final report on a therapeutic trial. | Q55499879 | ||
| Frequency of ASCA Seropositivity in Children with Cystic Fibrosis | Q59276901 | ||
| Wnt pathway-related gene expression during malignant progression in ulcerative colitis | Q62977731 | ||
| Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays | Q73178637 | ||
| Anti-Saccharomyces cerevisiae antibodies--a novel serologic marker for Behçet's disease | Q78350809 | ||
| Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA | Q80446255 | ||
| Crohn disease | Q81686009 | ||
| ??? | Q28303013 | ||
| Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC | Q24336321 | ||
| Mutation and cancer: statistical study of retinoblastoma | Q24618185 | ||
| Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays | Q24814806 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| The value of serologic markers in indeterminate colitis: a prospective follow-up study | Q28216203 | ||
| A simple index of Crohn's-disease activity | Q28259898 | ||
| Inflammatory bowel disease | Q29616286 | ||
| Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin-fixed paraffin-embedded tissues using western blotting | Q33401334 | ||
| The Rb/E2F pathway: expanding roles and emerging paradigms | Q34052659 | ||
| Tumor promotion by caspase-resistant retinoblastoma protein | Q34081405 | ||
| Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis | Q34091635 | ||
| The immunological and genetic basis of inflammatory bowel disease | Q34216426 | ||
| Nuclear expression of β-catenin promotes RB stability and resistance to TNF-induced apoptosis in colon cancer cells | Q34314699 | ||
| Retinoblastoma tumor suppressor: where cancer meets the cell cycle | Q34543916 | ||
| The RB and p53 pathways in cancer | Q34804764 | ||
| Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role | Q35351273 | ||
| Genetic and pathogenetic insights into inflammatory bowel disease | Q35577401 | ||
| Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis. | Q35596945 | ||
| Biomarkers in inflammatory bowel disease: current practices and recent advances | Q35840853 | ||
| Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease | Q36125752 | ||
| Medical treatment of inflammatory bowel diseases. | Q36148164 | ||
| beta-Catenin signaling in biological control and cancer. | Q36939963 | ||
| Diagnostics of inflammatory bowel disease | Q36993565 | ||
| Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation | Q37363209 | ||
| Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes | Q38304141 | ||
| Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis | Q41904328 | ||
| Recent trends in the epidemiology of inflammatory bowel diseases: up or down? | Q42726365 | ||
| Signal-dependent protection from apoptosis in mice expressing caspase-resistant Rb. | Q42809724 | ||
| Mucosal healing and anti TNFs in IBD. | Q43139094 | ||
| pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease | Q43531998 | ||
| Lipid peroxide-induced redox imbalance differentially mediates CaCo-2 cell proliferation and growth arrest | Q44086652 | ||
| Oxidative stress induces protein phosphatase 2A-dependent dephosphorylation of the pocket proteins pRb, p107, and p130. | Q44350742 | ||
| Blockade of tumor necrosis factor-induced Bid cleavage by caspase-resistant Rb. | Q46374579 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Crohn's disease | Q1472 |
| immunohistochemistry | Q899285 | ||
| retinoblastoma | Q500695 | ||
| P304 | page(s) | e70786 | |
| P577 | publication date | 2013-08-14 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Immunohistochemical analysis of retinoblastoma and β-catenin as an assistant tool in the differential diagnosis between Crohn's disease and ulcerative colitis | |
| P478 | volume | 8 |
Search more.